Adial Pharmaceuticals Acquires Azora Therapeutics and Secures Up to $64 Million Financing

Adial Pharmaceuticals (NASDAQ: ADIL) announced the acquisition of Azora Therapeutics, a biotechnology company focused on inflammatory diseases, and a concurrent financing package of... Read More

The post Adial Pharmaceuticals Acquires Azora Therapeutics and Secures Up to $64 Million Financing appeared first on citybiz.